Pharmaceutical GMP transformation of small and medium industrial enterprises the problems to be studied.docVIP

Pharmaceutical GMP transformation of small and medium industrial enterprises the problems to be studied.doc

  1. 1、本文档共6页,可阅读全部内容。
  2. 2、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
  3. 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  4. 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
  5. 5、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
  6. 6、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们
  7. 7、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
  8. 8、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
Pharmaceutical GMP transformation of small and medium industrial enterprises the problems to be studied

 PAGE \* MERGEFORMAT 6 Pharmaceutical GMP transformation of small and medium industrial enterprises the problems to be studied Recently, in order to understand the small and medium enterprise development, medicine, I Task Force group to Sichuan, Guizhou, Yunnan, Inner Mongolia, Guangxi, Anhui, Hunan and other places, in part, state, city, medium and small pharmaceutical companies to conduct field trips and research. And with local authorities and some pharmaceutical companies to influence and restrict the formation of small and medium pharmaceutical companies a key element of competitive advantage in interviews and questionnaires, found that GMP transformation of the impact of medium and small pharmaceutical companies cause for concern. 1, a considerable number of industrial manufacturing enterprises are busy GMP transformation is simply too busy to take into account other issues, the result is that most pharmaceutical companies have transformed the GMP exist in varying degrees, scale, and benefits decline; plant beautiful, the competitiveness of products reduction and other issues. Such as Sichuan, a city a total of 21 pharmaceutical companies, its fixed assets of about 1.8 billion, this is only five off-site business transformation that is invested 220 million yuan, of which an enterprise value of just over 1000 million yuan, now, scientific research strength, very weak more than 30 kinds of drugs amp;amp; Poor’s to maintain production, while the off-site transformation on the land of 120 acres, 50 million yuan for the four finance GMP transformation, but what the compliance post-production varieties, and strive to equipment that does not idle Querang boss helpless awake at night. In 2004 output reached 1 million psychological expectations, with the first quarter sales of only 8.6 million falls far short of 24 million bank loan August 30 has expired; Guizhou Miao a drug manufacturer, had produced only a plaster , but not ratified the symbol, this time for m

文档评论(0)

hhuiws1482 + 关注
实名认证
文档贡献者

该用户很懒,什么也没介绍

版权声明书
用户编号:5024214302000003

1亿VIP精品文档

相关文档